37,7% L-carnitine-L-tartrate, bulking agent sorbitols
Pairs Well MGF Pairs systemic IGF-1 receptor signalling with local satellite-cell activation - complementary mechanisms behind muscle hypertrophy research
The GLP-1RA are limited to use in individuals without established cardiovascular disease which limits the use widely but provides its benefit for at risk population
GLP-1 drugs are a clear example: They target a single signaling system yet can help improve obesity, diabetes, heart disease and kidney disease all at once
More specifically, this helps regulate: Appetite and satiety Food intake and cravings Insulin secretion in response to meals Rate of gastric emptying GLP-1 receptor agonist medications mimic this hormone and act on the brain and gut to reduce hunger, slow digestion, and improve blood sugar management
doi: 10.1016/j.jhepr.2025.101363 90